Blueprint Medicines Corpo... (BPMC)
NASDAQ: BPMC
· Real-Time Price · USD
129.46
0.18 (0.14%)
At close: Jul 17, 2025, 3:59 PM
Blueprint Medicines Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for BPMC stock have an median target of 129, with a low estimate of 125 and a high estimate of 135. The median target predicts a decrease of -0.36% from the current stock price of 129.46.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 125 | 130.75 | 129 | 135 |
| Change | -3.45% | 1.00% | -0.36% | 4.28% |
Latest Analyst Insight Report
Scotiabank has downgraded Blueprint Medicines to S... Unlock content with Pro Subscription
Updated Jun 02, 2025
| Rating | Jan 25 | Feb 25 | Mar 25 | Apr 25 | May 25 | Jun 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 5 | 3 | 3 | 1 | 0 |
| Hold | 1 | 0 | 1 | 0 | 0 | 11 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 3 | 1 | 11 |
Financial Forecast this Year
Revenue This Year
721.41M
from 508.82M
Increased by 41.8%
Revenue Next Year
953.93M
from 721.41M
Increased by 32.2%
EPS This Year
-0.7
from -1.07
Increased by 34.6%
EPS Next Year
0.92
from -0.7
Increased by -31.4%